$1.65
$0.00
(0.00%)
Quote as of 1:39 PM EST on 02/10/12
RESPONSE GENETICS, INC.
NASDAQ:RGDX
|
$1.65
|
|
| Today's Open | $1.68 |
|---|---|
| Previous Close | $1.65 |
| Daily Range | $1.65 - $1.79 |
| 52-Week Range | $0.81 - $3.05 |
| Market Cap | $32.24M |
| P/E Ratio | -11.00 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 15,040 |
| Average Daily Volume | 28,181 |
| Current FY EPS | -$0.14 |
RGDX Information
| Description |
|---|
| The Company is engaged in the research and development of its own pharmacogenomic cancer diagnostic tests based on its proprietary technologies. |
| Sector |
| Healthcare |
| Industry |
| Life Sciences Tools and Services |
News & Commentary
Response Genetics Test Target Patients That Xalkori Can Help
A Simplified ASCO 2011 List for Biotech Investor Research
UPDATE 1-Response Genetics inks deal with Glaxo, shares soar
